CYTOCHROMA
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapies designed to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.
CYTOCHROMA
Industry:
Biotechnology Clinical Trials Pharmaceutical
Founded:
1996-01-01
Address:
Kingston, Ontario, Canada
Country:
Canada
Website Url:
http://www.cytochroma.com
Total Employee:
51+
Status:
Closed
Contact:
847-236-7707
Total Funding:
75.83 M USD
Technology used in webpage:
SPF Amazon GoDaddy DNS AWS Global Accelerator AppRiver
Current Advisors List
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2006-06-29 | Proventiv Therapeutics | Proventiv Therapeutics acquired by Cytochroma | N/A |
Investors List
Caisse de Depot et Placement du Quebec
Caisse de Depot et Placement du Quebec investment in Series C - Cytochroma
Canadian Medical Discoveries Fund
Canadian Medical Discoveries Fund investment in Series C - Cytochroma
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma investment in Series C - Cytochroma
VentureLink LP
VentureLink LP investment in Series C - Cytochroma
Novo Holdings
Novo Holdings investment in Series C - Cytochroma
VenGrowth Asset Management
VenGrowth Asset Management investment in Series C - Cytochroma
BDC Capital Corporation
BDC Capital Corporation investment in Series C - Cytochroma
GrowthWorks Capital
GrowthWorks Capital investment in Series C - Cytochroma
GeneChem
GeneChem investment in Series C - Cytochroma
VenGrowth Asset Management
VenGrowth Asset Management investment in Series C - Cytochroma
Official Site Inspections
http://www.cytochroma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cytochroma"
Cytochroma - LinkedIn
Cytochroma | 1,036 followers on LinkedIn. Accelerating global drug development | Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse ...See details»
Cytochroma - Crunchbase Company Profile & Funding
Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated …See details»
Dr Kate Cameron - Founder & CEO at Cytochroma | The Org
In 2017, they became the CEO and founder of Cytochroma Limited, and in 2018 they were awarded a BBSRC RSE Enterprise Fellowship at the Royal Society of Edinburgh. Dr Kate …See details»
Cytochroma Inc. | BDC.ca
Cytochroma is a clinical-stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin …See details»
Cytochroma 2025 Company Profile: Valuation, Funding …
Information on valuation, funding, cap tables, investors, and executives for Cytochroma. Use the PitchBook Platform to explore the full profile.See details»
Advanced human iPSC cell models to predict clinical
Location Roslin Innovation Centre Easter Bush Estate Edinburgh EH25 9RG ScotlandSee details»
Cytochroma - 2025 Company Profile, Funding & Competitors
Mar 28, 2025 Cytochroma is a seed company based in Edinburgh (United Kingdom), founded in 2017 by Kate Cameron. It operates as a Developer of human tissue models for research …See details»
CYTOCHROMA LIMITED overview - Find and update company …
CYTOCHROMA LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Cytochroma Inc. - Markham, Canada - bionity.com
May 27, 2010 Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical …See details»
Female Founder Spotlight: Dr Kate Cameron - The …
Aug 14, 2021 Dr. Kate Cameron is the founder and CEO of Cytochroma a contract research organisation that creates an accurate, fast and powerful testing platform to transform drug discovery and development.See details»
Cytochroma - Crunchbase Company Profile & Funding
Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin …See details»
Cytochroma - Products, Competitors, Financials, Employees, …
Cytochroma is a clinical-stage specialty pharmaceutical company focused on developing and commercializing products to treat and prevent the clinical consequences of vitamin D …See details»
Scottish life sciences company behind 'mini-livers' secures £1 …
Dec 20, 2021 Scottish life sciences company behind ‘mini-livers’ secures £1 million growth injection Cytochroma, a Scottish life sciences company behind “ethical” alternatives to animal …See details»
Roslin-based ethical drug development company Cytochroma …
Dec 16, 2021 Cytochroma, a life sciences company that provides ethical, sustainable and accurate alternatives to animal testing in drug discovery and development, has secured nearly …See details»
Roslin-based ethnical drug development company secures £1m …
Dec 16, 2021 Cytochroma, a life sciences company which provides ethical and accurate alternatives to animal testing in drug discovery and development, has secured nearly £1m to …See details»
Contract Research Services - Cytochroma
We provide standard and bespoke in vitro studies as a service to fast-track clinical success.See details»
Advanced human iPSC cell models to predict clinical ... - Cytochroma
The FDA Modernization Act 2.0 has driven the use of cell based systems to predict toxicity and replace animal systems where possible. Cytochroma is a pioneer in providing the most diverse …See details»
In-cell architecture of the mitochondrial respiratory chain
Mar 20, 2025 The precise organization of these complexes in native cells is debated. We used in situ cryo–electron tomography to visualize the native structures and organization of several …See details»
Advanced human iPSC cell models to predict clinical ... - Cytochroma
Physiologically relevant and fully functional cell models manufactured to-scale and available in a constant supply.See details»
ORGANOIDS, SPHEROIDS AND TINY ORGANS - Cytochroma
Cytochroma’s tiny hearts, containing ventricular cardiomyocytes, cardiac endothelial cells and cardiac fibroblasts. These tint organs self assemble over time and form stable beating …See details»